How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male Participants
Clinical trial NCT07573449 · COMPLETED
Trial details
- NCT number
- NCT07573449
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2025-01-22
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.